These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 21331077)

  • 1. Molecular determinants of Smac mimetic induced degradation of cIAP1 and cIAP2.
    Darding M; Feltham R; Tenev T; Bianchi K; Benetatos C; Silke J; Meier P
    Cell Death Differ; 2011 Aug; 18(8):1376-86. PubMed ID: 21331077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming cancer cell resistance to Smac mimetic induced apoptosis by modulating cIAP-2 expression.
    Petersen SL; Peyton M; Minna JD; Wang X
    Proc Natl Acad Sci U S A; 2010 Jun; 107(26):11936-41. PubMed ID: 20547836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRAF2-binding BIR1 domain of c-IAP2/MALT1 fusion protein is essential for activation of NF-kappaB.
    Garrison JB; Samuel T; Reed JC
    Oncogene; 2009 Apr; 28(13):1584-93. PubMed ID: 19234489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Potent SMAC Mimetics that Sensitize Cancer Cells to TNF Family-Induced Apoptosis.
    Welsh K; Milutinovic S; Ardecky RJ; Gonzalez-Lopez M; Ganji SR; Teriete P; Finlay D; Riedl S; Matsuzawa S; Pinilla C; Houghten R; Vuori K; Reed JC; Cosford ND
    PLoS One; 2016; 11(9):e0161952. PubMed ID: 27617834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of cIAP1 and cIAP2 in murine B lymphocytes constitutively activates cell survival pathways and inactivates the germinal center response.
    Gardam S; Turner VM; Anderton H; Limaye S; Basten A; Koentgen F; Vaux DL; Silke J; Brink R
    Blood; 2011 Apr; 117(15):4041-51. PubMed ID: 21300983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitor of Apoptosis Protein-1 Regulates Tumor Necrosis Factor-Mediated Destruction of Intestinal Epithelial Cells.
    Grabinger T; Bode KJ; Demgenski J; Seitz C; Delgado ME; Kostadinova F; Reinhold C; Etemadi N; Wilhelm S; Schweinlin M; Hänggi K; Knop J; Hauck C; Walles H; Silke J; Wajant H; Nachbur U; W Wei-Lynn W; Brunner T
    Gastroenterology; 2017 Mar; 152(4):867-879. PubMed ID: 27889570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smac mimetics and TNFalpha: a dangerous liaison?
    Wu H; Tschopp J; Lin SC
    Cell; 2007 Nov; 131(4):655-8. PubMed ID: 18022360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct BIR domains of cIAP1 mediate binding to and ubiquitination of tumor necrosis factor receptor-associated factor 2 and second mitochondrial activator of caspases.
    Samuel T; Welsh K; Lober T; Togo SH; Zapata JM; Reed JC
    J Biol Chem; 2006 Jan; 281(2):1080-90. PubMed ID: 16282325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CLL cells are resistant to smac mimetics because of an inability to form a ripoptosome complex.
    Maas C; Tromp JM; van Laar J; Thijssen R; Elias JA; Malara A; Krippner-Heidenreich A; Silke J; van Oers MH; Eldering E
    Cell Death Dis; 2013 Aug; 4(8):e782. PubMed ID: 23990022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based design and molecular profiling of Smac-mimetics selective for cellular IAPs.
    Corti A; Milani M; Lecis D; Seneci P; de Rosa M; Mastrangelo E; Cossu F
    FEBS J; 2018 Sep; 285(17):3286-3298. PubMed ID: 30055105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smac mimetics activate the E3 ligase activity of cIAP1 protein by promoting RING domain dimerization.
    Feltham R; Bettjeman B; Budhidarmo R; Mace PD; Shirley S; Condon SM; Chunduru SK; McKinlay MA; Vaux DL; Silke J; Day CL
    J Biol Chem; 2011 May; 286(19):17015-28. PubMed ID: 21393245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell Lymphoma.
    Yang Y; Kelly P; Shaffer AL; Schmitz R; Yoo HM; Liu X; Huang DW; Webster D; Young RM; Nakagawa M; Ceribelli M; Wright GW; Yang Y; Zhao H; Yu X; Xu W; Chan WC; Jaffe ES; Gascoyne RD; Campo E; Rosenwald A; Ott G; Delabie J; Rimsza L; Staudt LM
    Cancer Cell; 2016 Apr; 29(4):494-507. PubMed ID: 27070702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structures of the TRAF2: cIAP2 and the TRAF1: TRAF2: cIAP2 complexes: affinity, specificity, and regulation.
    Zheng C; Kabaleeswaran V; Wang Y; Cheng G; Wu H
    Mol Cell; 2010 Apr; 38(1):101-13. PubMed ID: 20385093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cIAP1 and cIAP2 limit macrophage necroptosis by inhibiting Rip1 and Rip3 activation.
    McComb S; Cheung HH; Korneluk RG; Wang S; Krishnan L; Sad S
    Cell Death Differ; 2012 Nov; 19(11):1791-801. PubMed ID: 22576661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Birinapant (TL32711), a bivalent SMAC mimetic, targets TRAF2-associated cIAPs, abrogates TNF-induced NF-κB activation, and is active in patient-derived xenograft models.
    Benetatos CA; Mitsuuchi Y; Burns JM; Neiman EM; Condon SM; Yu G; Seipel ME; Kapoor GS; Laporte MG; Rippin SR; Deng Y; Hendi MS; Tirunahari PK; Lee YH; Haimowitz T; Alexander MD; Graham MA; Weng D; Shi Y; McKinlay MA; Chunduru SK
    Mol Cancer Ther; 2014 Apr; 13(4):867-79. PubMed ID: 24563541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TRAF2 must bind to cellular inhibitors of apoptosis for tumor necrosis factor (tnf) to efficiently activate nf-{kappa}b and to prevent tnf-induced apoptosis.
    Vince JE; Pantaki D; Feltham R; Mace PD; Cordier SM; Schmukle AC; Davidson AJ; Callus BA; Wong WW; Gentle IE; Carter H; Lee EF; Walczak H; Day CL; Vaux DL; Silke J
    J Biol Chem; 2009 Dec; 284(51):35906-15. PubMed ID: 19815541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor (TNF) signaling, but not TWEAK (TNF-like weak inducer of apoptosis)-triggered cIAP1 (cellular inhibitor of apoptosis protein 1) degradation, requires cIAP1 RING dimerization and E2 binding.
    Feltham R; Moulin M; Vince JE; Mace PD; Wong WW; Anderton H; Day CL; Vaux DL; Silke J
    J Biol Chem; 2010 Jun; 285(23):17525-36. PubMed ID: 20356846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CIAP2 inhibits anigen receptor signaling by targeting Bcl10 for degredation.
    Hu S; Alcivar A; Qu L; Tang J; Yang X
    Cell Cycle; 2006 Jul; 5(13):1438-42. PubMed ID: 16775419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of non-canonical NF-κB signaling as a critical mediator of Smac mimetic-stimulated migration and invasion of glioblastoma cells.
    Tchoghandjian A; Jennewein C; Eckhardt I; Rajalingam K; Fulda S
    Cell Death Dis; 2013 Mar; 4(3):e564. PubMed ID: 23538445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An apoptosis-independent role of SMAC in tumor suppression.
    Qiu W; Liu H; Sebastini A; Sun Q; Wang H; Zhang L; Yu J
    Oncogene; 2013 May; 32(19):2380-9. PubMed ID: 22751125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.